Does surgery still have a role in stage III NSCLC in the era of immunotherapy? The surgeon’s view

Date

29 Sep 2019

Session

Immunotherapy in thoracic malignancies: What has been achieved in 2019?

Presenters

Ad Verhagen

Authors

A. Verhagen

Author affiliations

  • Cardio-thoracic Surgery, Radboud University Medical Center, 6525 GA - Nijmegen/NL
More

Resources

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings